Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001241
Filing Date
2024-08-08
Accepted
2024-08-08 17:15:19
Documents
75
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240630x10q.htm   iXBRL 10-Q 1872697
2 EX-31.1 tmb-20240630xex31d1.htm EX-31.1 10580
3 EX-31.2 tmb-20240630xex31d2.htm EX-31.2 10669
4 EX-32.1 tmb-20240630xex32d1.htm EX-32.1 5482
  Complete submission text file 0001410578-24-001241.txt   8156908

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20240630.xsd EX-101.SCH 68888
6 EX-101.CAL tmb-20240630_cal.xml EX-101.CAL 55334
7 EX-101.DEF tmb-20240630_def.xml EX-101.DEF 234936
8 EX-101.LAB tmb-20240630_lab.xml EX-101.LAB 463221
9 EX-101.PRE tmb-20240630_pre.xml EX-101.PRE 403988
78 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240630x10q_htm.xml XML 1312332
Mailing Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9
Business Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9 905-541-3833
Target Group Inc. (Filer) CIK: 0001586554 (see all company filings)

EIN.: 463610035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55066 | Film No.: 241189637
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)